Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome

Virchows Archiv

Volumn 465, Issue 3, 2014, Pages 291-298

  Ren, Meijing ^a   Liu, Fangfang ^a   Zhu, Yufen ^a   Li, Yaqing ^a   Lang, Ronggang ^a   Fan, Yu ^a   Gu, Feng ^a   Zhang, Xinmin ^b   Fu, Li ^a  

^a KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Carcinoma associated fibroblasts; Caveolin 1; Invasive micropapillary carcinoma; Progression free survival; Stroma

Indexed keywords

CAVEOLIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADIPOCYTE; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CARCINOMA ASSOCIATED FIBROBLAST; CONTROLLED STUDY; DISTANT METASTASIS; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; INVASIVE MICROPAPILLARY BREAST CARCINOMA; MAJOR CLINICAL STUDY; MYOEPITHELIUM CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR RECURRENCE; TUMOR VOLUME; BREAST TUMOR; CHEMISTRY; MIDDLE AGED; MORTALITY; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, PAPILLARY; CAVEOLIN 1; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84908213887     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-014-1614-6     Document Type: Article

References (38)

1. Schauer IG, Sood AK, Mok S et al (2011) Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia 13:393–405
2. Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 15:166–179
3. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB et al (2010) Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 9:3256–3276
4. Guido C, Whitaker-Menezes D, Capparelli C et al (2012) Metabolic reprogramming of cancer-associated fibroblasts by TGF-beta drives tumor growth: connecting TGF-beta signaling with "Warburg-like" cancer metabolism and L-lactate production. Cell Cycle 11:3019–3035
5. Pavlides S, Tsirigos A, Vera I et al (2010) Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle 9:2201–2219
6. Sotgia F, Martinez-Outschoorn UE, Howell A et al (2012) Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol 7:423–467
7. Park SS, Kim JE, Kim YA et al (2005) Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology 47:625–630
8. Mercier I, Casimiro MC, Wang C et al (2008) Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy. Cancer Biol Ther 7:1212–1225
9. Sloan EK, Ciocca DR, Pouliot N et al (2009) Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol 174:2035–2043
10. Witkiewicz AK, Dasgupta A, Sotgia F et al (2009) An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 174:2023–2034
11. Witkiewicz AK, Dasgupta A, Sammons S et al (2010) Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Cancer Biol Ther 10:135–143
12. El-Gendi SM, Mostafa MF, El-Gendi AM (2012) Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome. Pathol Oncol Res 18:459–469
13. Simpkins SA, Hanby AM, Holliday DL et al (2012) Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J Pathol 227:490–498
14. Zekioglu O, Erhan Y, Ciris M et al (2004) Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology 44:18–23
15. Walsh MM, Bleiweiss IJ (2001) Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol 32:583–589
16. Fu L, Ikuo M, Fu XY et al (2004) Relationship between biologic behavior and morphologic features of invasive micropapillary carcinoma of the breast. Zhonghua Bing Li Xue Za Zhi 33:21–25
17. Reis-Filho JS, Ellis IO (2012) WHO classification of tumours of the breast. IARC, Lyon
18. Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784–2795
19. Cantiani L, Manara MC, Zucchini C et al (2007) Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. Cancer Res 67:7675–7685
20. Wikman H, Kettunen E, Seppanen JK et al (2002) Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21:5804–5813
21. Kato K, Hida Y, Miyamoto M et al (2002) Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94:929–933
22. Nam KH, Lee BL, Park JH et al (2013) Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology 80:87–94
23. Liu P, Rudick M, Anderson RG (2002) Multiple functions of caveolin-1. J Biol Chem 277:41295–41298
24. Liu F, Lang R, Wei J et al (2009) Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathology 54:741–750
25. Li W, Liu F, Lei T et al (2010) The clinicopathological significance of CD44+/CD24−/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast. Pathol Res Pract 206:828–834
26. Elsheikh SE, Green AR, Rakha EA et al (2008) Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer 99:327–334
27. Li T, Sotgia F, Vuolo MA et al (2006) Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am J Pathol 168:1998–2013
28. Di Vizio D, Morello M, Sotgia F et al (2009) An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 8:2420–2424
29. Jia Y, Wang N, Wang J et al (2014) Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Ann Surg Oncol 21:329–336
30. Pavlides S, Tsirigos A, Migneco G et al (2010) The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 9:3485–3505
31. Salem AF, Whitaker-Menezes D, Lin Z et al (2012) Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. Cell Cycle 11:2545–2556
32. Sotgia F, Martinez-Outschoorn UE, Pavlides S et al (2011) Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res 13:213
33. Sanchez-Alvarez R, Martinez-Outschoorn UE, Lin Z et al (2013) Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention. Cell Cycle 12:289–301
34. Senetta R, Stella G, Pozzi E et al (2013) Caveolin-1 as a promoter of tumour spreading: when, how, where and why. J Cell Mol Med 17:325–336
35. Goetz JG, Minguet S, Navarro-Lerida I et al (2011) Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 146:148–163
36. Ayala G, Morello M, Frolov A et al (2013) Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. J Pathol 231:77–87
37. Xia H, Khalil W, Kahm J et al (2010) Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol 176:2626–2637
38. Bodmer M, Meier C, Krahenbuhl S et al (2010) Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33:1304–1308